Described are compounds that bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also described are methods of use of the compounds described herein in ameliorating or treating aspartic protease related disorders in a subject in need thereof.

 
Web www.patentalert.com

< USE OF POL III PROMOTERS FOR CONTROLLED EXPRESSION OF THERAPEUTIC PROTEINS

< METHODS AND COMPOSITIONS FOR TREATING DISORDERS CAUSED BY A DEFICIENCY IN A GENE PRODUCT OF A CLN GENE

> METHODS AND COMPOSITIONS FOR LOCATING SNP HETEROZYGOSITY FOR ALLELE SPECIFIC DIAGNOSIS AND THERAPY

> CRYSTALLINE GENISTEIN SODIUM SALT DIHYDRATE

~ 00618